The goal of the study is to examine brain changes in gene carriers who do not have symptoms of FTD, and find factors that predict disease course in people who already have, or may later be diagnosed with FTD.
This study will use PET neuroimaging to determine the amount of tau protein in the brain and to explore the relationship between presence of tau and clinical course of Parkinson's disease (PD) and dementia with Lewy bodies (DLB).
This study examines the effect of cognitive enhancement programs on age related changes in memory and attention.
This trial will study the efficacy and tolerability of drugs targeting Alzheimer's disease in patients with a genetic predisposition to the disease.
This survey aims to help researchers better understand how the experience of caregiving affects mental health and wellbeing.
This telephone support intervention aims to help caregivers by providing them with the support and strategies they need to manage challenging behaviors.
This study examines the progression and symptoms of primary progressive aphasia (PPA) and differentiates subtypes of PPA.
This study examines how the proteins tau and amyloid affect brain regions and relate to symptoms of typical and atypical Alzheimer's disease (AD).
The goal of the study is to obtain a uniform set of data from individuals who have various types of dementia (e.g., Alzheimer’s disease, frontotemporal degeneration, lewy body dementia, etc..) and from healthy older individuals in order to understand how dementia (a decline in mental ability) develops in the human brain.